Division of Nephrology, Ospedale Carità, Via Ospedale, 6600 Locarno, Switzerland.
BMC Nephrol. 2011 Apr 6;12:14. doi: 10.1186/1471-2369-12-14.
A rapid decrease of serum potassium concentrations during haemodialysis produces a significant increase in blood pressure parameters at the end of the session, even if effects on intra-dialysis pressure are not seen. Paradoxically, in animal models potassium is a vasodilator and decreases myocardial contractility. The purpose of this trial is to study the precise haemodynamic consequences induced by acute changes in potassium concentration during haemodialysis.
In 24 patients, 288 dialysis sessions, using a randomised single blind crossover design, we compared six dialysate sequences with different potassium profiles. The dialysis sessions were divided into 3 tertiles, casually modulating potassium concentration in the dialysate between the value normally used K and the two cut-off points K+1 and K-1 mmol/l. Haemodynamics were evaluated in a non-invasive manner using a finger beat-to-beat monitor.
Comparing K-1 and K+1, differences were found within the tertiles regarding systolic (+5.3, +6.6, +2.3 mmHg, p < 0.05, < 0.05, ns) and mean blood pressure (+4.3, +6.4, -0.5 mmHg, p < 0.01, < 0.01, ns), as well as peripheral resistance (+212, +253, -4 dyne.sec.cm-5, p < 0.05, < 0.05, ns). The stroke volume showed a non-statistically-significant inverse trend (-3.1, -5.2, -0.2 ml). 18 hypotension episodes were recorded during the course of the study. 72% with K-1, 11% with K and 17% with K+1 (p < 0.01 for comparison K-1 vs. K and K-1 vs. K+1).
A rapid decrease in the concentration of serum potassium during the initial stage of the dialysis-obtained by reducing the concentration of potassium in the dialysate-translated into a decrease of systolic and mean blood pressure mediated by a decrease in peripheral resistance. The risk of intra-dialysis hypotension inversely correlates to the potassium concentration in the dialysate.
NCT01224314.
血液透析过程中血清钾浓度的快速下降会导致透析结束时血压参数显著升高,即使对透析期间的血压没有影响。矛盾的是,在动物模型中,钾是一种血管扩张剂,会降低心肌收缩力。本试验的目的是研究血液透析过程中钾浓度急性变化引起的精确血液动力学后果。
在 24 名患者的 288 次透析中,我们使用随机单盲交叉设计比较了 6 种不同钾谱的透析液序列。透析分为 3 个三分位,随意调节透析液中钾浓度在正常使用 K 值和两个截止点 K+1 和 K-1mmol/l 之间。使用手指脉搏波监测仪进行非侵入性血流动力学评估。
比较 K-1 和 K+1,在三分位内发现收缩压(+5.3、+6.6、+2.3mmHg,p<0.05、<0.05、ns)和平均血压(+4.3、+6.4、-0.5mmHg,p<0.01、<0.01、ns)以及外周阻力(+212、+253、-4dyne.sec.cm-5,p<0.05、<0.05、ns)存在差异。心排量呈非统计学显著负趋势(-3.1、-5.2、-0.2ml)。在研究过程中记录了 18 次低血压发作。K-1 组占 72%,K 组占 11%,K+1 组占 17%(K-1 与 K 相比和 K-1 与 K+1 相比,p<0.01)。
透析初期通过降低透析液中钾浓度快速降低血清钾浓度,导致收缩压和平均血压降低,外周阻力降低介导。透析期间低血压的风险与透析液中的钾浓度呈负相关。
NCT01224314。